Patents by Inventor Gionata Scalcinati

Gionata Scalcinati has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230287435
    Abstract: The present disclosure provides microbial organisms having decreased production of unwanted by-products (e.g, pyruvate-, CO2—, TCA-derived by-products; acetate; ethanol; and/or, alanine) to enhance carbon flux through acetyl-CoA, which can increase production of acetyl-CoA derived compounds (e.g, 1,3-BDO, MMA, and (3R)-hydroxybutyl (3R)-hydroxybutyrate, or any other acetyl-CoA derived compounds), and products made from any of these compounds. Also provided are one or more exogenous nucleic acids encoding enzymes that can decrease production of unwanted by-products (e.g, aldehyde dehydrogenase, acetyl-CoA synthase, amino acid dehydrogenase, alanine racemase, and/or citrate synthase), and/or one or more gene attenuations occurring in genes (e.g., acetolactate synthase) that result in decreased production of unwanted by-products. Various combinations of the exogenous nucleic acids and gene deletions are also provided in the present disclosure.
    Type: Application
    Filed: October 28, 2020
    Publication date: September 14, 2023
    Inventors: Harish Nagarajan, Gionata Scalcinati, Tae Hoon Yang
  • Publication number: 20220403420
    Abstract: The present disclosure provides microbial organisms having increased availability of co-factors, such as NADPH, for increasing production of various products, including 1,3-BDO, MMA, (3R)-hydroxybutyl (3R)-hydroxybutyrate, amino acids, 3HB-CoA, adipate, caprolactam, 6-ACA, HMD A, or MAA, and products made from any of these. Also provided are one or more exogenous nucleic acids encoding an enzyme expressed in a sufficient amount to increase availability of NADPH, where the exogenous nucleic acid includes one or more of ATP-NADH kinase, pntAB, nadK, and gapN. Also provided are one or more gene attenuations occurring in genes, such as NDH-2, that result in an increased ratio of NADPH to NADH. Various combinations of the exogenous nucleic acids and gene deletions are also provided in the present disclosure. The present disclosure also provides methods of making and using the same, including methods for culturing cells, and for the production of the various products.
    Type: Application
    Filed: October 22, 2020
    Publication date: December 22, 2022
    Inventors: Harish Nagarajan, Gionata Scalcinati, Tae Hoon Yang
  • Patent number: 9745602
    Abstract: The present invention relates to the control of gene expression by a heterologous glucose-regulated promoter, to microorganisms in which gene expression is controlled by a heterologous glucose-regulated promoter and to methods using said microorganisms for the production of terpenes during glucose-limited fed-batch fermentation.
    Type: Grant
    Filed: June 1, 2012
    Date of Patent: August 29, 2017
    Assignee: FIRMENICH SA
    Inventors: Laurent Daviet, Michel Schalk, Jens Nielsen, Verena Siewers, Christoph Knuf, Gionata Scalcinati
  • Publication number: 20140113343
    Abstract: The present invention relates to the control of gene expression by a heterologous glucose-regulated promoter, to microorganisms in which gene expression is controlled by a heterologous glucose-regulated promoter and to methods using said microorganisms for the production of terpenes during glucose-limited fed-batch fermentation.
    Type: Application
    Filed: June 1, 2012
    Publication date: April 24, 2014
    Applicant: FIRMENICH SA
    Inventors: Lauren Daviet, Michel Schalk, Jens Nielsen, Verena Siewers, Christoph Knuf, Gionata Scalcinati